Inactief instrument

Andere talen CannPal Animal Therapeutics Limited

Aandelen

CP1

AU000000CP17

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Layton Mills and Margaret Curtis agreed to acquire 52% stake in CannPal Animal Therapeutics Limited from AusCann Group Holdings Ltd for AUD1.	10-03-23
AusCann Group Holdings Ltd completed the acquisition of CannPal Animal Therapeutics Limited from Merchant Opportunities Fund, managed by Merchant Funds Management Pty Ltd and others.	11-03-21
Cannpal Animal Therapeutics : Narrows Fiscal H1 Loss on Higher Revenue	19-02-21
Cannpal Animal Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2020	18-02-21
AusCann : CannPal Managing Director to Lead Merged Company Formed With AusCann; CannPal Rises 11%	08-01-21
AusCann Group Holdings Ltd (ASX:AC8) and CannPal Enter Into Scheme of Arrangement	16-11-20
AusCann Group Holdings Ltd entered into a scheme implementation deed to acquire CannPal Animal Therapeutics Limited from Merchant Opportunities Fund, managed by Merchant Funds Management Pty Ltd and others for AUD 16.9 million.	16-11-20
CannPal Animal Therapeutics Limited Announces Resignation of Max Johnston as Non-Executive Director	28-08-20
CannPal Animal Therapeutics : CBD Substantially Improves Atopic Dermatitis Symptoms in Dogs	21-07-20
CannPal Animal Therapeutics Limited Announces Completion of its Safety and Efficacy Study for DermaCann	21-07-20
CannPal Animal Therapeutics Limited Announces FDA Establishes Investigational New Animal Drug file for CPAT-01	10-03-20
Cannpal Animal Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2019	25-02-20
CannPal Animal Therapeutics Limited Enters into Exclusive Licensing Agreement with Commonwealth Scientific and Industrial Research Organisation	05-01-20
49,365,405 Ordinary Shares of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19
2,000,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19
625,000 Class A Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19
1,500,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19
7,250,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19
625,000 Class B Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19
625,000 Class C Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25-10-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CannPal Animal Therapeutics Limited

Aandelen

CP1

AU000000CP17

Andere talen

Filters